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Abstract: Advances in nanoparticle-based systems constitute a promising research area with
important implications for the treatment of bacterial infections, especially against multidrug resistant
strains and bacterial biofilms. Nanosystems may be useful for the diagnosis and treatment of viral
and fungal infections. Commercial diagnostic tests based on nanosystems are currently available.
Different methodologies based on nanoparticles (NPs) have been developed to detect specific agents
or to distinguish between Gram-positive and Gram-negative microorganisms. Also, biosensors based
on nanoparticles have been applied in viral detection to improve available analytical techniques.
Several point-of-care (POC) assays have been proposed that can offer results faster, easier and at
lower cost than conventional techniques and can even be used in remote regions for viral diagnosis.
Nanoparticles functionalized with specific molecules may modulate pharmacokinetic targeting
recognition and increase anti-infective efficacy. Quorum sensing is a stimuli-response chemical
communication process correlated with population density that bacteria use to regulate biofilm
formation. Disabling it is an emerging approach for combating its pathogenicity. Natural or synthetic
inhibitors may act as antibiofilm agents and be useful for treating multi-drug resistant bacteria.
Nanostructured materials that interfere with signal molecules involved in biofilm growth have been
developed for the control of infections associated with biofilm-associated infections.
Keywords: nanoparticles; signaling; bacterial infections; viral infections; quorum sensing;
point-of-care testing
1. Introduction
Common infectious diseases have been reasonably well controlled by a broad range of
anti-infective agents, but recently, due to the massive use of these drugs, new resistant strains have
appeared. This fact and the interest in improving existing therapies compel the scientific community
to keep searching for new ways to combat infections [1]. In this area, nanotechnology has a variety of
practical roles to play, from drug delivery to diagnostics. Nanoparticulate systems offer a versatile
platform that can offer different intrinsic properties depending on the nature of the nanoparticle.
Moreover, they can be functionalized, which broadens their potential and opens new possibilities for
customizing them according to the intended aim [2].
Nanoparticles (NPs) can include a wide variety of molecules, offering a multifunctional platform
for drug targeting, diagnostic techniques and even theranostics that have already demonstrated their
potential in clinical trials [1,3–5].
Advances in nanoparticle-based systems for the diagnosis and treatment of infectious diseases
constitute a promising area of research with important implications for the treatment of bacterial
infections, especially in the fight against multidrug resistant strains and bacterial biofilms. In addition,
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nanosystems may be useful in the diagnosis and treatment of viral infections such as HIV and hepatitis,
the treatment of fungal infections, or as vaccines [6,7].
Nanoparticles functionalized with specific molecules such as proteins, antibodies or DNA may
modulate pharmacokinetics and targeting recognition and increase the efficacy of anti-infective drugs.
The characteristics of certain types of nanoparticles and additional functionalization give them the
ideal properties for application in diagnostic analysis, even allowing for the miniaturization and
simplification of some traditional techniques of pathogen detection [1].
In addition, nanoparticles constitute an interesting platform for theranostic applications.
For instance, systems that combine drugs and certain kinds of nanoparticles allow therapeutic agent
delivery as well as the imaging of a target organ or tissue [4,8,9].
An interesting use of nanoparticles is in the design of biosensors: analytical devices that
incorporate biological material, biologically derived material or a biomimic with a physicochemical
transducer or a transducing microsystem [10].
Biosensors could allow for the measurement of a specific analyte or group of analytes that
can be detected through a receptor fixed onto the surface of a transducer that detects the signal
produced by the analyte recognition. Although this concept was initially developed for cancer
biomarkers [10,11], if an appropriate biomarker were identified, it could be applied similarly to other
pathological conditions [12–14].
Nanoparticles offer a platform in which different kinds of proteins and peptides such as specific
ligands or enzymes can be included [15–18] and allow the identification and/or quantification of
molecules of interest, even in multiplex detection.
Additionally, very sophisticated multilayered nanoparticles could be designed to include targeting
molecules, as both biosensors for detecting surrogate molecules expected in infected cells prior to
the delivery of a nanoparticle cargo, and moreover, as a feedback control mechanism for the amount
delivered [19].
Quorum sensing is a stimuli-response chemical communication process correlated with
population density that bacteria use to regulate biofilm formation. The disabling of quorum sensing is
an emerging approach for combating its pathogenicity. Natural or synthetic quorum-sensing inhibitors
may act as anti-biofilm agents and be useful in treating multi-drug resistant bacteria.
Nanostructured materials which interfere with the signal molecules involved in biofilm growth
have been developed for the control of biofilm-associated infections.
The aim of this review is to show the most recent advances in the role played by molecular
signaling via nanoparticles and nanomaterials in the diagnosis and treatment of infectious diseases.
2. Nanoparticles for Bacterial Detection
Traditional methods used for the identification of bacteria are based on the culture of
the microorganisms on agar plates and the characterization of their phenotypic properties.
These techniques are laborious, slow and unspecific in some cases. New methods for the identification
of bacteria based on the principles of molecular biology have also been developed and specially
polymerase chain reactions (PCR) based methods [20,21]. In the last decade, different methods based
on the combination of sensitive techniques such as surface-enhanced Raman spectroscopy (SERS),
electrochemical methods or fluorescence methods combined with the use of nanoparticles, especially
metal nanoparticles, for rapid and sensitive identification of bacteria have been developed. In addition,
some of these methods also allow the killing of the bacteria. These methods have some general
advantages in comparison with traditional methods such as shorter analysis times and the possibility
to identify different types of bacteria simultaneously.
Different commercial tests based on nanosystems using biochemical, immunological and
bioluminescence procedures are currently available for detecting pathogenic agents. Methodologies based
on gold or silver nanoparticles, glass nanospheres or quantum dots among others, have been developed
to detect specific agents or to distinguish between Gram-positive and Gram-negative microorganisms.
Int. J. Mol. Sci. 2018, 19, 1627 3 of 28
Rapid and sensitive detection of pathogenic bacteria is an important research area considering its
implications for healthcare, the environment, food, etc. [6].
Traditionally, different physico-chemical and immunological methods have been developed
for bacterial detection such as fluorescence spectroscopy, mass spectrometry, enzyme-linked
immunosorbent assay, etc. [22].
The detection of bacteria using biosensors is not a new procedure [23,24]. However, in recent
years, important advances have been made in the development of biosensors based on immunological
methods that take advantage of the optical and electrical properties of nanoparticles, particularly metal
nanoparticles [25]. The combination of sensitive techniques such as magnetic sensors, Surface-enhanced
Raman Spectroscopy (SERS), electrochemical methods and fluorescence methods with different types
of nanoparticles such as gold, silver, magnetic, silica and functionalized nanoparticles, among others,
has allowed the development of very specific and sensitive methods for the diagnosis and killing of
bacteria, with numerous applications both in biomedicine and in other fields. The main applications of
these methods are the detection of multi-resistant bacteria in healthcare and veterinary practice and in
the food industry.
2.1. Magnetic Sensors
Magnetic nanoparticles labeled with antibodies may be used for bacterial detection.
The nanoparticle-antibodies conjugate, attach to the bacteria, and then the nanoparticles are removed
using an external magnetic field. Then, different methods of detection and quantification of bacteria,
such as scanning electron microscopy (SEM), transmission electron microscopy (TEM), fluorescence
microscopy etc., may be used [6,26].
Tuberculosis is a major health problem worldwide, especially in undeveloped countries, and about
3 million people are estimated to remain undiagnosed or untreated. In addition, Mycobacterium
tuberculosis strains are associated with higher morbidity and mortality in infected patients, making
their prevention, diagnosis and cure crucial [27,28].
A magnetoresistive biosensor to detect Mycobacterium bovis (BCG) bacteria for tuberculosis
diagnosis based on the use of magnetic nanoparticles has recently been developed [29]. This system
uses a magnetoresistive biochip whose surface is functionalized with specific BCG antibodies.
When magnetic nanoparticles reach the surface of a biochip a change in magnetoresistance is created
by the magnetic field and detected by the sensors [29]. This sensitive method is an alternative to
classical methods of detecting of tuberculosis such as the Ziehl–Neelsen sputum smear microscopy
image test for tuberculosis detection, which has a poor sensitivity.
In parallel, a magnetophoretic immunoassay sensor for early diagnosis of tuberculosis in the
culture supernatants from sputum samples has been developed. Antigens of Mycobacterium tuberculosis
such as culture filtrate protein (CFP)-10 may be detected by this method. The system uses two different
kinds of nanoparticles: gold nanoparticles for signaling and magnetic nanoparticles for separation
with two kinds of monoclonal antibodies [30].
2.2. Surface Enhanced Raman Spectroscopy (SERS)
Raman spectroscopy is a technique which provides information about the molecular vibrations of
molecules or groups of atoms when a monochromatic light is used. When laser light irradiates a sample,
scattered light is detected; this phenomenon is known as the Raman effect and a spectrum of the sample
is obtained by plotting the intensity of the scattered light against frequency. Raman spectroscopy
provides detailed specific sample characterization of the material analyzed and is widely used for
material identification.
Surface-enhanced Raman Spectroscopy (SERS) is a method that amplifies Raman signals using
nanoscale metal surfaces such as gold or silver among other metals. These metallic nanosystems are
called plasmonic nanoparticles and exhibit specific optical properties when exposed to laser light,
increasing the method’s sensitivity. Surface plasmons are electromagnetic waves that propagate on
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the surface of a conductor. Surface plasmon resonance (SPR) is a phenomenon associated with this
kind of nanoparticle that arises from the interaction between the surface plasmon of a nanoparticle
and an incident electromagnetic wave (e.g., laser), producing a quantum effect due to a change in its
electronic structure, which depends on the characteristics of the nanoparticle [31,32].
SERS is a powerful method for the identification of certain substances or organisms with some
limitations, such as interference related to the nature of the matrix [32]. An important application of
SERS is molecular detection and, more specifically, the detection of live bacteria, which has implications
for healthcare and the food industry [33,34].
Currently, the usual method for the detection of bacteremia is blood culture; however, in recent
years, different bacterial identification methods based on the use of SERS combined with metallic
nanoparticles have been proposed. They may be subdivided into label and label-free SERS
methods [34].
2.2.1. Label SERS
Label SERS is based on the use of SERS tags, which are entities incorporating metallic nanoparticles
that can be employed to label a target molecule and indirectly identify it by using SERS methods.
Plasmonic nanoparticles, mainly gold nanoparticles, may be used to synthetize SERS tags [35].
In addition, SERS tags may be functionalized using recognition molecules such as monoclonal
antibodies, aptamers or small molecules to increase specificity [34,36]. SERS tags are useful in biomedical
imaging with potential application in cancer therapeutics and infectious diseases detection [34,37].
Label SERS functionalized with monoclonal antibodies incorporating different kinds of
nanoparticles, such as silver or gold, have been proposed for the detection of different types of
bacteria, such as Salmonella and Staphylococcus aureus among others. Monoclonal antibodies with a high
recognition capacity to target a specific surface protein of bacteria are used [22,38,39].
Hybrid systems composed of gold nanoparticles conjugated with Rhodamine 6G (Rh6G)
modified monoclonal AC04 antibodies combined with single-walled carbon nanotubes (SWCNT)
with SERS detection have been developed for the selective detection and killing of multi-drug resistant
Salmonella typhimurium. This nanohybrid system provides a significant enhancement of the Raman
signal, increasing the method’s sensitivity. In addition, the near-infrared (NIR) irradiation of this
nanohybrid system produces bacterial death and selectively eradicates 99% of the bacteria [38]. Also,
nanoprobes prepared by the immobilization of a specific monoclonal antibody onto the surface of
nanoparticle beds, a microfluidic electrophoresis device and on-line SERS have been developed for the
rapid detection of Salmonella enterica and Neisseria lactamica with high sensitivity and specificity [22].
2.2.2. Label-Free SERS
In recent years, label-free methods for bacterial detection have been developed. One rapid
label-free detection method for bacteria in blood is based on the combination of a universal sample
preparation process using 10 mL of whole human blood treated with a lysis buffer and the use
of a bacterial concentrator to concentrate the microorganisms, producing an enriched sample of
viable microorganisms for downstream analysis by SERS. An aliquot is placed on a SERS chip
containing a SiO2 substrate coated with gold nanoparticles. This method allows for the detection
of microorganisms such as S. aureus or Escherichia among others with a very good specificity and
sensitivity and hence with important implications for clinical practice [40,41].
Another rapid real-time analysis based on a label-free SERS biosensor that uses the in situ
synthesis of silver nanoparticles has been developed for the identification of Gram-positive and
Gram-negative bacteria [42]. In addition, one specific label-free SERS method permits the identification
of Klebsiella pneumoniae resistant strains. In this method, an aluminosilicate substrate with a 50 nm
gold layer was used in a drop coated deposition SERS method. The method may be affected by the
heterogeneity of the sample and a multivariate statistical method was used for rapid subtyping of
resistant strains [43].
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Pseudomonas aeruginosa is a common bacteria in airway infections associated with patients with
cystic fibrosis. Hydrogen cyanide (HCN) is a P. aeruginosa biomarker with a specific signal in the
Raman spectrum. The use of highly sensitive gold-coated silicon nanopillar SERS substrate allows for
the enhancement of the Raman signal via the formation of electromagnetic “hot spots”. This method
allows for the detection of the biomarker HCN from clinical P. aeruginosa isolates [44].
2.3. Plasmonic Nanocavities
Localized surface plasmons (LSP) are a phenomenon generated by light when it interacts with
conductive NPs that are smaller than the incident wavelength. Nanostructures with LSP resonances are
used to enhance electric signals near the nanostructure. A single nanohole in a metal layer is capable
of supporting a LSP [45]. New technologies based on nanocavity-shaped photonic crystals with strong
plasmonic signals have been developed with potential applications in bacterial detection [46–48].
This method involves the production of quasi-periodic plasmonic nanocavities by patterning
a Thue–Morse (T–M) array of nanoholes in a polymeric film to obtain metallic gold nanocavities
that allow the propagation of surface plasmons [46,47]. Surface plasmonic resonances of metallic
nanostructures can be either suppressed or enhanced depending on their geometric size [49].
These kinds of structures, combined with SERS, permit rapid and highly sensitive bacteriophage
detection of pathogenic bacteria such as Brucella sp. [48].
2.4. Electrochemical Biosensors
Electrochemical affinity biosensors are based on immunoassays methodology combined with
electrochemical detection. Electrochemical detection is a very sensitive method which uses the electrical
current that is produced from oxidation or reduction reactions associated with biological processes.
These methods may be used for bacterial detection of molecular biomarkers from different pathogenic
infections [50–52].
Escherichia coli O157:H7 is a bacteria associated with food poisoning via the release of a toxin
called Shiga that causes diarrhea and severe damage to the kidneys. Biosensors based on gold
nanoparticles combined with polyclonal antibodies have been developed. A complex formed by
magnetic nanoparticles conjugated with monoclonal antibodies was used for the separation of E. coli
from the solution. Then the magnetic complex was used for the electrochemical detection of E. coli
bacteria [53].
More recently, another group has been working on an electrochemical aptasensor that
uses coaxial capillary with immune magnetic nanoparticles for the separation of bacteria [54].
Streptavidin-modified magnetic nanoparticles (MNP) are injected into the coaxial capillary and are
subjected to a magnetic field. Biotinylated polyclonal antibodies (PAbs) are injected to produce
immune magnetic nanoparticles and a sample containing bacteria is injected into the capillary
to form a MNP-PAb bacteria complex called “magnetic bacteria”. Gold nanoparticles (AuNP)
modified with the aptamer against the bacteria and urease are injected into the system to produce
a MNP-PAb-bacteria-aptamer-GNP-urease complex called “enzymatic bacteria”. Urea is injected into
the capillary and then ammonium and carbonate ions are produced by the catalysis of the urea by the
bacteria. This produces a reduction in the impedance that is measured by the PCB gold electrode and
is related to the concentration of the bacteria. This method is very rapid and sensitive for the detection
of E. coli O157:H7 (Figure 1) [54].
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Figure 1. Electrochemical aptasensor for the detection of E. coli O157:H7 [54]. Reproduced with permission.
Nanodecorated electrodes have also recently been developed for the detection of bacteria such as
E. coli and Streptococcus pneumoniae [55,56].
This methodology is based on the adherence of metallic nanoparticles to the bacteria’s surface
after which nano-decorated bacteria may be detected through electrochemical detection [56]. Silver
nanoparticles may interact with the urface of Gram-negative teria such as E. coli, especially in
the range of 1–10 nm, disturbing its functioning and producing a bactericidal effect [57]. Using this
principle, E. coli bacteria were decorated with silver nanoparticles around 10 nm in diameter due to the
high affinity of silver nanoparticles to the surface of the bacteria. The chronoamperometric response of
the silver nanoparticles was measured using a carbon fiber electrode. The E. coli concentration on the
sample may be correlated with the amperometric response [56].
In the same way, detection of pn umococ us such as S. pneumoniae has been carried out
using electrical methods by measuring the change in electrical properties such as conductance of
nanodecorated bacteria. In this case, the bacteria are captured by the pneumococcal C-polysaccharide
(PnC) antibody and then gold nanoparticles are conjugated with the PnC antibodies on the surface
of the bacteria. By using interdigitated electrodes, the conductance change is correlated with the
bacteria concentration. S. pneumoniae concentrations of about 10 CFU/ mL may be detected with this
method [55].
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An alternative is to use nanodecorated impedance electrode sensors to integrate the capture,
killing and sensitive detection of the bacteria into a multi-function system. This electrode sensor
was manufactured using Zn-CuO nanoparticles and Graphene oxide nanosheets on a nickel porous
electrode. With this kind of electrode, capture and killing of bacteria may be realized as seen in
Figure 2. In addition, a high detection sensitivity of about 10 CFU/mL of E. coli in blood samples was
obtained [58].
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2.5. Fluorescence Methods
Fluorescence immunoassay is a sensitive technique that can be used in the measurement of many
substances, mainly proteins, and in the quantification of antigens from viruses or bacteria. Fluorescein
isothiocyanate (FITC) is a common fluorescent label that produces conjugates with proteins and other
biological materials with applications in imaging and sensitive analysis. Different kinds of fluorescent
nanoparticle conjugates may be used for bacterial detection.
Immunoassay using fluorescent antibody-nanoparticle conjugates may be applied for the
detection of Gram-negative bacteria such as E. coli or P. aeruginosa. Conjugates f functionalized silica
nanoparticles with FITC allow fo the rapid detection of Escherichia coli O157:H7 b flow cyt metry
in beef samples. Rabbit anti-E. coli O157:H7 antibody was used to rec gnize E. coli O157:H7. Protein
A, a stable protein extracted from S. aureus, was used for antibody coupling on silica nanoparticle
surfaces. The method is rapid, selective and sensitive for the detection of E. coli [59].
Immunoassay methodology using small molecules as a substitute for antibodies with a strong
affinity to the bacteria, such as certain antibiotics, have been proposed. Vancomycin is a glycopeptide
antibiotic with affinity to gram-positive bacteria due to the multivalent hydrogen binding effect.
Mesoporous silica nanoparticles modified with vancomycin have been developed for the recognition
and killing of Gram-positive bacteria. Mesopores of vancomycin silica n noparticles were loaded with
a fluorescent mole ul (FITC). After incubation with FITC and bacteria, th detection was performed
by measuring the fluorescence with high specificity and sensitivity. With this method, the detection
and killing of Gram-positive bacteria such as S. aureus was performed [60].
Also, glucose stabilized silver nanoparticles labeled with a pyrimidine fluorescent derivative were
attached to the monoclonal antibody (IgG) of Pseudomonas aeruginosa. The fluorescence response was
able to be enhanced when the fluorophore was localized near a metal surface due to the characteristics
of the metallic nanoparticle. This nanosystem allows for the detection of bacteria in water, agriculture
samples, soil, and different types of food [61,62].
CdSe/ZnS quantum dots incorporated into SiO2 microspheres constitute a fluorescent labeled
system for the detection of S. typhimurium. The conjugate between fluorescent nanoparticles and
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bacteria may be detected by fluorescence microscopy. The detection limit was 3.3 × 102 CFU/mL,
and this method may be applied to the detection of other bacteria [63].
Bacterial detection and killing in liquid- and solid-phase systems can also be achieved using
surface-coatable NIR response fluorescent nanoparticles. Polydopamine (PdA) is a biomaterial with
adhesive properties. Carbonized polydopamine (FDA) may be functionalized with polyethylenimine
(PEI) to form fluorescent carbon nanoparticles (FDA:PEI). The cationic surface of these nanoparticles
may bind to the anionic bacterial wall of Gram-positive and Gram-negative bacteria such as S. aureus or
E. coli through changes in the fluorescent signal. In addition NIR irradiation of carbonized nanoparticles
produces heat and kills the bacteria [64].
Food poisoning produced by bacteria is an important cause of disease and death. The bacteria
that cause the most illnesses and deaths are Salmonella enterica, E. coli and Clostridium sp.
Janus nanoparticles are colloidal systems with two spatial domains that have different
physicochemical properties. The use of Janus micromotors as mobile sensors has been proposed for
the detection of toxins released by enterobacteria. Magnetocatalytic Janus micromotors encapsulating
phenylboronic acid (PABA) modified graphene quantum dots based on platinum nanoparticles that
produce blue fluorescence emission allow the fast monitoring of enterobacterial contamination in
food [65,66].
2.6. Fluorescence Resonance Energy Transfer (FRET)
Fluorescence resonance energy transfer (FRET) is a mechanism describing energy transfer between
two light-sensitive substances. A donor chromophore, in its electrically excited state due to the
excitation of incident light, may transfer energy to an acceptor chromophore. This methodology
permits the evaluation of the distance between two chromophores to within several nanometers.
A limitation of FRET is that this transfer process is effective only when the distance separating two
molecules is smaller than 10 nanometers. FRET allows for the measurement of the interaction between
biological molecules within nanoscale [67].
An interesting application of this technique is the study of molecular interactions inside living
cells with improved resolution and sensitivity, with potential applications on pathogen-induced host
receptor signaling based on protein–protein interactions related with signaling events in infected host
cells [68,69].
FRET has recently been proposed for the detection and quantification of Mycobacterium tuberculosis
DNA using gold nanoparticles and fluorometric detection [70].
3. Nanoparticles for Viral Detection
Different kinds of nanoparticles have demonstrated their potential for the diagnosis, treatment
and prevention of viral infections in many applications, especially those nanoparticles with viral
material or systems that mimic virus characteristics. This section focuses on the diagnostic techniques
developed for the identification and/or quantification of viruses themselves, and more specifically of
the viruses that have been more thoroughly investigated and have more relevance [71–77].
It is interesting to remark that in therapeutics against viruses, some specific kinds of nanoparticles
have arisen: the so-called “virus-like particles” (VLPs) [78]. They are nanoparticles formed from viral
proteins that assemble in structures similar to authentic virus particles although they lack infectious
nucleic acid sequences. VLPs can be used for the detection of pathogens, as therapeutic agent carriers
and as scaffolds for vaccines against bacterial/viral pathogens [79].
They have been thoroughly investigated in the field of contrast agents, and have been observed
to harness the intrinsic properties inherited from their original virus, such as the natural interaction
of viruses with certain cells. Moreover, VLPs can also be customized with a variety of biomolecules
which significantly broadens their potential uses and advantageous properties [15,18,80].
As previously stated for bacterial detection, the addition of nanoparticles, to common diagnostic
techniques, usually improves their characteristics, leading to a higher sensitivity of detection systems
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in some cases allowing for the detection of even femtomolar amounts of virus [81]. Early diagnosis is
always desirable for the control of infectious diseases. Different strategies have been implemented
using nanoparticles to improve analytical technique characteristics, even allowing the development of
simple and fast point-of-care (POC) assays to diagnose in situ in remote regions.
Although devices based on nanoparticles could imply higher production costs in some cases,
other approaches such as the nanoparticle-based immunochromatographic strips, can be easily and
cheaply scaled to mass production.
On the other hand, even for some techniques reviewed here that have a similar sensitivity to the
usual conventional techniques used for virus diagnosis, the application of nanoparticles offers the
key advantage of resulting in diagnostic tests that can be applied in these remote locations with very
basic equipment and a lack of specialist trained personnel. The unique and versatile properties of
nanoparticles themselves and the molecules that can be associated with them enable fast, sensitive and
cost effective diagnoses [82].
3.1. Magnetic Nanoparticles
As previously mentioned for bacterial detection, magnetic nanoparticles have also been used for
the separation of viruses associated with them, which can lead to an enrichment of the sample in the
component of interest and a consequent enhancement of detection sensitivity. In addition, magnetic
nanoparticles can also be implemented in biosensors as reporter labels that allow magnetoelectronic
viral detection [83].
Nanoparticles from different magnetic iron oxides present superparamagnetism, which allows
the sorting of such superparamagnetic iron oxide nanoparticles (SPIONs) by exposure to magnetic
fields. Magnetic-activated cell sorting (MACS) with antibody-conjugated magnetic particles has been
coupled to other signals for specific antigen detection [84].
Functionalized magnetic NPs have been applied in different diagnostic techniques to
detect hepatitis antigens [84–86] or DNA in combination with PCR amplification [87] among
other possibilities.
Different portable biosensors based on magnetic nanoparticles have been developed for rapid
virus detection. Electrically active magnetic (EAM) polyaniline nanostructures have been used
for Influenza A virus due to their association with antibodies against the surface glycoprotein
hemagglutinin (HA). Making polyaniline electrically active by the addition of a protic solvent allows
these structures also to be used as the electrical transducer of a rapid, specific and sensitive electrical
biosensor [88].
With a similar aim, magnetic nanobeads coated with specific antibodies and combined with
a microfluidic chip with an interdigitated array microelectrode have been implemented in a biosensor
able to quantify the influenza virus on the basis of the impedance measured for the complexes formed
with viruses present [89]. This system showed sensitivity and specificity similar to the usual PCR-based
diagnostic method.
Another method, based on magnetizable nanoparticles and electrochemical detection has been
designed for the detection of E6-HPV16 gene, which has been demonstrated to be implicated in
mechanisms of human papilloma virus (HPV)-related carcinogenesis. Its combination with PCR
improved DNA isolation in comparison with standard PCR, allowing detection of a lower oncogene
level [90].
3.2. SERS
As has been previously explained, the application of nanoparticles to Raman spectroscopy amplifies
the signals, leading to SERS that has been applied for the detection of different kinds of virus.
For hepatitis detection, a highly selective and sensitive immunoassay has been developed with
a SERS-active substrate incorporated into a microfluidic device. The formation of a sandwich structure
of fuchsin-labeled immuno-Au nanoflowers with HBsAg and the antibody immobilized on the
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SERS-active substrate based on Au–Ag coated GaN allows for virus detection with low detection
limits [91].
The nanoplasmonic properties of gold nanoparticles have been applied in human
immunodeficiency virus (HIV) load quantification from whole blood samples. Thus, a detection
platform with highly specific antiviral antibodies fixed to the biosensing surface has been demonstrated
to be able to detect and quantify multiple HIV subtypes and could also be adapted for the detection of
other pathogens that have well-described biomarkers [92].
Variations of the methods based on these inherent properties of gold nanoparticles have been
applied in respiratory virus, even allowing for the distinction among different influenza viruses and
hepatitis viruses [93–96]. An optofluidic-nanoplasmonic sensor that could be used as a POC Ebola
analysis, even in biodefense contexts, has been designed. This nanohole based sensing platform has
demonstrated its ability to detect intact viruses from biologically relevant media with an easy sample
preparation and the authors suggest that it could be extrapolated to other viruses [97].
3.3. Electrochemical Biosensors
Due to their own nature, metallic nanoparticles such as gold nanoparticles have been widely used
in electrochemical detection [98].
Different biosensors based on nanoparticles have been applied in influenza virus detection,
among others [99,100], since they have ideal characteristics for designing biosensors for POC assays
that can offer diagnostic results faster, easier, at lower cost than conventional techniques and with
good selectivity and sensitivity.
Electrochemical biosensors based on gold nanoparticles demonstrated their ultrasensitivity in
detecting single-stranded DNA (ssDNA) of HPV and also hepatitis B virus (HBV) [101]. An electrode
integrating graphene and polyaniline nanowires has also been proposed as a way to improve its DNA
detection sensitivity [102].
On the other hand, immunoassays based on complementary metallicoxide semiconductor (CMOS)
image-sensor technology using an indium nanoparticle (InNP) substrates, have been used for hepatitis
virus detection [103].
In the research field of Ebola diagnosis, experts have expressly pointed to the need to develop
a biosensor that allows the detection of Ebola viruses at the point of care. By analogy with the
application of nanoparticles to diagnostic techniques developed for other viruses and on the basis
that miniaturized chips with immobilized antibodies have demonstrated their capacity to detect pM
levels of other biomarkers [104,105], some authors propose that the miniaturization of electrochemical
immune-sensing methodology would be a feasible means to develop devices for rapid and in situ
Ebola screening [106].
3.4. Fluorescence-Based Methods
The use of fluorescent nanoconstructs as probes has been proposed for the improvement of virus
detection techniques based on immunoassays [107,108]. Some authors have developed a fluorescent
diagnostic device compatible with a smartphone camera that transmits its data to a central data base
system, thus proposing an interesting POC testing method for influenza screening that could even
result in an international real-time surveillance system [109].
Some authors have also combined metallic nanoparticles with fluorescence enzyme-linked
immunosorbent assay (FELISA) for hepatitis B diagnosis. Thus, by employing dually labeled
gold nanoparticles, an enhancement in HBsAg detection limits of conventional ELISA has been
observed [110].
Gold nanoparticles and quantum dots have been used for virus detection by FRET, as electron
acceptor or donor respectively in FRET pairs. The fluorophore conjugated to specific antibodies
undergoes a conformational change when binding to the virus, which changes the distance between
the fluorescent molecules or the fluorescent/quencher molecules and a measurable change in the
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resonance energy transfer is observed. They have been applied to Porcine Reproductive and
Respiratory Syndrome Virus (PRRSV) but could be used for other viruses by including the appropriate
antibody [111].
Gold and silver nanowires have also been applied as quenchers to immobilize Molecular Beacon
hairpin [94]. This structure, consisting of looped strands of DNA with a fluorophore and a fluorescence
quencher at the opposite terminus, takes on its open bright state in the presence of the specific target
strand of DNA or RNA. Nanowire combinations such as nanobarcodes could accomplish multiplexed
assays by designing the oligonucleotides of different nanowires to be complementary to target DNA
sequences of different viruses, as has been demonstrated for the simultaneous detection of hepatitis A
virus, hepatitis C virus, West Nile Virus, HIV and severe acute respiratory syndrome virus [112].
Quantum dots (QD) have also been explored just as a fluorophore. They allow the detection
and monitoring of viral infection through the detection of bioconjugates obtained due to antibody
affinity or other interactions. Using different colored QDs could even provide additional information
simultaneously, such as structural changes in cytoskeleton. They have demonstrated better sensitivity
than respiratory syncytial virus (RSV) detection based on antibodies conjugated to fluorescein
isothiocyanate (FITC) [94]. They have also demonstrated their potential for influenza virus detection in
clinical samples without any pretreatment [113] and for early stage diagnosis of HIV infections [114].
QDs have also been suggested for hepatitis detection but no better sensitivity than other methods
has been proved for this virus [73,115].
3.5. Other Optical Biosensing Methods
Colorimetric detection has been used in the detection of respiratory viruses. An enhanced
plasmonic ELISA was developed for RSV detection by combining alkaline phosphatase-mediated
AuNPs-based colorimetric assay with metal ion sensitized dephosphorylation of ATP [116].
Regarding influenza virus, alkaline phosphatase (ALP) has been used as a signal tag for
immunoreaction. Color change was observed in the presence of the virus due to silver deposition
on the surface of gold nanoparticles induced by the enzyme. Coupled with magnetic enrichment,
this method has been demonstrated to be simple, fast and highly sensitive, allowing H9N2 virus
detection directly in complex samples [117].
Metallic nanoparticles have been demonstrated to improve HIV-1 p24 antigen assay. Nanoarrays
obtained by nanolithography have shown an enhancement in the detection limit as well as faster
detection than the conventional colorimetric enzyme-linked immunosorbent assay (ELISA) [75].
A microchip based on microfluidics and nanoparticles has been developed which allows diagnosis
on-site of both HIV and syphilis. This device replicates the ELISA steps and allows the detection of
antibody markers within scarcely few minutes at low cost, with enough sensitivity and specificity and
requiring just a few microliters of blood sample. Thus, this mChip miniaturizes ELISA techniques and,
implemented in a handheld instrument easy to operate, provides a fast and affordable assay that can
be used in the most remote regions [118].
Dual-luminophore-doped silica nanoparticles with different surface modifications have been
studied for multiplexed analysis. In combination with flow cytometry, it has been suggested that these
systems have interesting advantageous properties in the detection of pathogens, especially for those
that have problems with normal dyes due to their minimal specific antigens. Results revealed that these
nanoparticles have high signal amplification, excellent photostability and easy surface bioconjugation
for biomarker detection, which highlights this system as an ideal biolabeling reagent in antigens and
nucleic acids detection [119].
Other methods based on colorimetric detection have been applied to virus detection. Through
association of gold nanoparticles with reverse transcription loop-mediated isothermal amplification,
a very simple assay for hepatitis E was developed, whose results can be evaluated with the naked eye
due to color changes. It has been proposed as an alternative to other expensive and time-consuming
methods usually employed [120]. Fe3O4 magnetic nanoparticles have been also applied as nanozyme
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probes, harnessing their natural intrinsic peroxidase-like activity that can be visually detected due to
the obvious color reaction. By labelling them with specific antibodies and in the presence of peroxide
substrates, they have been studied for immunomagnetic Ebola virus detection [121].
Other DNA detection methods based on chemiluminescent labels and magnetic nanoparticles
use DNA capture probes coupled to magnetic nanoparticles. By including a long spacer arm in
magnetic nanoparticles, freedom for DNA hybridization and chemiluminescence detection is increased.
An ultrasensitive method based on this system has been developed for the hepatitis B virus as a proof
of concept [85], but it could be applied to other viruses.
3.6. Other Applications of Nanoparticles in Imaging Diagnostic Techniques
Other imaging techniques, if not exactly used to identify pathogen presence, can be used in
evaluating tissue and organ functionality, and taking all the obtained information as a whole can
help in the diagnosis of pathological conditions, as has been proved for liver imaging using SPION-
enhanced magnetic resonance imaging (MRI) in hepatic cancer [122].
Considering the extended and consolidated application of gadolinium (Gd) as a contrast agent,
Gd based nanoparticles have been explored. Different modifications of these nanoparticles with
chelators, linkers, conjugation, coating and so on have been studied in order to enhance image contrast,
which would lead to a better visualization of the diseases [15].
Some authors have suggested that virus-like particles can be used for encapsulation of contrast
agents, improving their properties, as has been demonstrated for Fe3O4 nanoparticles encapsulated
into hepatitis B core as a T2 MRI contrast imaging agent [80].
3.7. Virus-Based Nanoparticles in Viral Genetic Material Detection
Viral capsids have been used to shield nucleic acids increasing their stability during assays
and storage, in order to be used as controls in diagnostic assays. Thus, the so-called “armored
RNA” has been used for a variety of techniques to detect pathogens, including a vast variety of
viruses [123]. Different modifications have been studied, for instance, to allow the simultaneous
detection of several viruses. Following the same line, encapsulation of DNA in viral capsids has been
also studied [15,124–127].
4. Bacterial Treatment: Quorum Sensing
Bacteria are able to communicate with each other through secreted signaling factors, also named
autoinducers. These chemical signals are synthesized intracellularly and released to the extracellular
medium where they are recognized by the adjacent cells activating the expression of related genes [128].
The autoinducer activity and the behavioral changes are only triggered when a threshold level is
reached [129–133]. These events require, then, high cell densities (to accumulate sufficient signal).
The minimum behavioral unit has been described as a quorum of bacteria and thus, this mode of
bacterial communication has been termed quorum sensing (QS) [134] as illustrated in Figure 3.
The QS process among cells was first discovered to control bioluminescence in the marine bacteria
Vibrio fischeri, where for low cell densities an homoserine lactone is secreted to the medium, whereas
for high cell densities it is accumulated inside when it triggers the transcription of luminescence
genes [133,135]. It is now known that QS modulates many biological properties in bacteria as the
production of virulence factors and the bacterial biofilms [136–138]. Thus, in Pseudomonas aeruginosa,
whose quorum sensing system has been the most studied, it regulates the production of several
compounds that play important roles in biofilm formation. This includes rhamnolipids, lectin A
(LecA)/LecB and pyochelin and pyoverdine siderophores [132,139–142].
Hence, the functional criteria defining a QS system is: a cell density-dependent accumulation [143]
of a small diffusible molecule that is recognized by adjacent cells, in which it triggers a specific
transcriptional response [144].
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Different QS pathways have been identified [130]. The quorum sensing systems can be classified
into several groups, based on the type of auto-inducer used [129].
The QS system regulated by acyl-homoserinelactone (AHLs) is a standard mechanism most
commonly employed by Gram-negative bacteria species. AHLs, also known as autoinducer-1
(AI-1), are molecules composed of a lactone ring and an aliphatic chain whose length and
nature may vary for different species [145]. The LuxI/LuxR protein system controls this type of
communication [146,147]. A LuxI protein synthesizes an acylated homoserine-lactone (AHL) using
the substrate S-adenosylmethionine (SAM) and an acylated acyl-carrier protein (acyl-ACP) [148] AHL
molecule, which starts the quorum sensing circuit, generally diffuses freely across the cell envelope
and accumulates in the local environment [149]. When an adequate level of AHL is reached, it is
recognized by a LuxR protein that results in the activation of related genes [129,146].
Other types of homoserine-lactone synthase, LuxM and AinS, have been discovered in vibrio
species. Although they present important sequence differences with LuxI, their substrates and reaction
kinetics are similar [128,150,151].
Gram-positive bacteria generally employ for communication small peptidic molecules named
auto-inducing peptides (AIP). The synthesis of these peptide signals occurs in the cell ribosome and
they undergo some modifications to reach a matured form. Specialized transporters are responsible for
its active transport out of the cell. Detection of these peptide signals can occur either at the surface of the
cell or intracellularly [149]. The simplest Gram-positive quorum sensing system was first discovered
in Lactococcus lactis and Streptococcus pneumoniae [152]. A precursor of the auto-inducing peptide
synthesized in the cell ribosome is modified and processed by an ATP-binding cassette (ABC) complex
and then transported out of the cell At a certain AIP concentration, a two-component regulatory system
transduces the signal through a phosphorylation cascade to response regulators that activate or repress
target genes (Figure 4) [129,149,150,152–154].
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The third main category of autoinducers is AI-2, used by bacteria for interspecies communication.
It is a furanosyl borate diester, produced by a LuxS protein [129,156]. It has been identified in
over 60 bacterial species although only a few of them possess receptors that sense and respond
to the presence of AI-2. This autoinducer regulates the production of virulence factors in Vibrio
vulnificus [157–159], Serratia marcescens [159] and Clostridium perfringens [160]. However, the specific
role of AI-2 in other species of bacteria remains unresolved [129,130].
Other molecules are also employed by intraspecies QS. This includes 2-heptyl-3hydroxy-
4-quinolone, also referred to as Pseudomonasquinolone signal (PQS). In Pseudomonas aeruginosa,
virulence factors such as pyocyanin, elastase and LecA lectin, which significantly impact the infection
process are regulated by the PQS [149,161].
The diffusible signal factor (DSF) family are cis 2-unsaturated fatty acids that have been found
in many bacterial species where they regulate motility, biofilm formation, iron uptake, extracellular
polysaccharide (EPS), extracellular enzyme production and virulence [162]. It has also been proposed
that they could play a role in interspecies communication [163]. These kinds of autoinducers were
first described for Xantomonas spp. They have now also been found in P. aeruginosa and other
species [162,164]. A signal turn over mechanism for DSF has been described [165,166].
Other QS systems found in various Vibrio spp. as well as in Legionella utilize α hidroxiketones
(AHKs) as signaling molecules [149].
Furthermore, it is becoming evident that bacteria do not usually rely on only one signal molecule,
and different QS systems with hierarchical or parallel performance have been described [167].
4.1. Quorum Sensing Interfering Agents: An Alternative to Antibiotics for Controlling Bacterial Infections
Nowadays, the increase in resistant bacterial strains and the lack of new antibiotics make it
necessary to search for new strategies to fight infections. Due to the important role that quorum sensing
plays in bacterial virulence, the disruption of this bacterial communication systems is attracting a great
deal of interest as a new antimicrobial strategy [131,168]. These are very promising approaches because
as they do not directly compromise bacterial survival, involve low selection pressure and thus yield
a lower occurrence of resistance [130,145].
This intervention strategy is named “quorum quenching” (QQ), a term used to include any
approach that interferes with proper microbial QS signaling [169–171]. This can be done at different
points: inhibition of autoinducer synthesis, degradation of the autoinducer and interception of its
interaction with the receptor [130,172].
Depending on the type of regulation (i.e., whether quorum sensing induces or represses virulence),
the agents will need to either inhibit or stimulate quorum-sensing-regulated gene expression. The latter
is the case for the human pathogen Vibrio chlolerae, in which quorum sensing represses biofilm formation
and virulence factor production [130,168].
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Many compounds have been described as inhibiting the bacterial communication process.
Quorum sensing interfering (QSI) agents can be either natural or synthetic compounds, as well
as small molecules, enzymes and antibodies. Excellent and complete reviews of QS inhibitors have
been published [130,134,149,153,155,168,170,171].
There have been attempts to develop inhibitors of Lux synthases [132] like butyryl-SAM and
sinefungin [173]. However, the most extensively studied QSI strategies to date are degradation and
modification of the quorum sensing signals themselves and the use of autoinducer antagonists.
Most enzymes identified thus far target AHL, although enzymatic inactivation of other signals
has also been reported. The main source of those enzymes are another bacterial, fungal, plant or animal
species that secrete them as a defense mechanism against the QS that bacteria use to compete with
them [174].
There are three known classes of enzymes which target AHL signals: lactonases, acylases and
oxidorreductases. They are obtained from diverse bacterial species.
The lactonases belong to the metallo β lactamase superfamily. They inactivate AHL by
hydrolyzing the ester bond, causing the opening of the homoserinelactone ring Acylases break the
AHL amide, rendering the fatty acid and the homoserinelactone ring, products that do not show
any activity [174,175]. As the AHL of different bacterial species maintain the homoserinelactone ring,
lactonases are active for all of them [176,177]. Acylase activity depends on AHL fatty acid substitutes or
chain length, which show variations between species [178–180]. Oxidoreductases are the most recently
discovered AHL enzymes inactivating group. They modify but do not break AHL, transforming
oxo-AHL into the corresponding hidroxyAHL. This can affect AHL receptor binding [181,182].
QQ enzymes can also be found in animals. This is the case of mammalian paraoxonases,
a group of esterases present in sera and other tissues. They have shown hydrolytic activity for
N-(3-Oxododecanoyl)-L-homoserine lactone (3OC12-HSL) of Pseudomonas aeruginosa [183–185]
The use of autoinducer antagonists is another strategy used for inhibiting the QS. Many
compounds that are structurally similar to those of quorum sensing signal molecules have also
been identified [155,171]. The best studied QSI with this model of action are halogenated furanones,
a group of compounds initially obtained from red algae. These compounds can disrupt AHL signaling
pathways by reducing the affinity of the autoinducer to the Lux-R or by interfering with the signal
transduction. Also, some furanones are able to inhibit the synthase LuxS, the enzyme responsible for
AI-2 [168,186,187].
Many medicinal plants, species such as garlic, ginger, essential oils of cinnamon and clove are
also known to possess QSI activities. Carrot, chamomile, garlic and many peppers have been proven
to have anti-QS activity, although the mechanisms for many of them have not yet been identified. Also,
flavonoids such as baicalin, quercetin, naringenin, kempferol, apigenin have all been reported to be
efficient in antagonizing bacterial QS [155].
The question of whether anti-QS therapies should be used as postinfection interventions or as
prophylactic measures remains to be solved. In most studies, a prophylactic use has been studied
by administering the anti-QS agents at the same time as the pathogens inoculum and a profound
improvement in the infection outcome has been found [188–190]. Therapeutic benefits of QSI have
also been obtained against microorganisms such as Salmonella typhimurium and Serratia marcescens
when administering the anti-QS after the infection has developed [191,192]. This supports the use of
these products as new antibiotics.
4.2. Nanoparticles and Quorum Sense Inhibitors
Many nanoparticle systems have been proposed for biofilm control but here we are only going
over studies that correlate these systems with quorum sensing inhibition. Thus, we are focusing on the
research about the properties of nanomaterials as QS inhibitors as well as the use of these systems as
carriers of molecules with quorum quenching activity.
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The quorum quenching abilities of metals and metallic nanoparticles have been especially
highlighted [193]. The anti-QS activity of silver NPs has been the most widely studied among them
Silver nanoparticles showed a reduction of AHL bacterial synthesis in two soil Pseudomonas species at
sub-inhibitory concentrations. However, a species-dependence activity was observed [194]. In another
study, silver NPs reduced the levels of AHL and its transcriptional regulators LasIR and RhIiR in
Pseudomonas aeruginosa, inhibiting biofilm formation and the production of virulence factors such
as LasA protease, LasB elastase, pyocianin, pyoverdin, pyochelin, rhamnolipid and alginate [195].
Ant-iQS activity of silver NPs has also been assessed for uropathogens S. marcescens and Escherichia coli
resulting in the inhibition of QS virulence factors such a as prodigiosin and protease [192].
When AgCl was incorporated to TiO2 NPs (ATNPs), it also showed anti-QS activity against
the biosensor Chromobacterium violaceum, a Gram negative bacteria with acyl homoserine lactone
autoinducers. The anti-QS activity of ATNPs was achieved at a concentration that was 20 times lower
than the bactericidal concentration. TiO2 acted as a good supporting matrix, facilitating effective use
of silver by reducing the concentration required for bioactivity [196]. This strategy has been proposed
for packaging materials in order to prolong food shelf-life.
ZnO nanoparticles have also shown antibiofilm activity against Pseudomonas aeruginosa at
concentrations below its bactericidal level. The mechanism involves quorum sensing processes that
lead to an inhibition of biofilm formation and pyocyanin, pseudomonas quinolone signal (PQS) and
pyochelin production [197].
β-cyclodextrins are cyclic oligosaccharides used as excipients for the improvement of
water-solubility and bioavailability of medicinal products. They have been shown to non-specifically
bind to AHL, thus removing these signal molecules from the bacterial environment and disrupting
bacterial QS. Its fixation to the surface of silicon dioxide nanoparticles increases its quenching
ability [198].
Plain nanocapsules of another polysaccharide, chitosan, which contained an oil core stabilized
by a surfactant and coated by the polymer, also inhibited the quorum sensing of Escherichia coli [199].
In another study chitosan/pentasodium tripolyphosphate (TPP) NPs loaded with kaempherol showed
anti QS activity mediated by AHL as established using the biosensor Chromobacterium violaceum.
The encapsulated flavonoid could act as a stronger and longer acting quorum quencher than
kaempherol alone [200]. The encapsulation of other flavonoids, quercetin and baicalein, in chitosan
nanocapsules also improved its antiquorum sensing activity in comparison with the free form.
The anti-QS activity was measured in the E. coli Top 10 biosensor and the mechanisms proposed
were inhibition of the autoinducer synthase, (a modification of LuxR receptor) that could affect its
union with the DNA promoter, or the blockage of the diffusion of AHL to the cytosol [201].
The insolubility of many molecules that are inhibitors of QS limit their potential to be used
as drugs [131]. Recently, a PqsR antagonist, thus linked to the PQS signal: 2-heptyl-6-nitro-
4-oxo-1,4-dihydroquinoline-3-carboxamide, was described as strongly inhibiting the virulence of
Pseudomonas aeruginosa. As it is a very lipophilic molecule, it was formulated in solid lipid nanoparticles
(SLN) and the anti-QS activity was evaluated. It was found that the loaded NPs were superior to the
free QSI in the inhibition of pyocianin formation. Also, a strong inhibition of this virulence factor was
achieved with plain SLN. This effect was not due to the killing of bacteria and was attributed to the
emulsifiers present in the formulation, mainly Tween 80 and Poloxamer 407 [202].
The highly hydrophobic molecule (cLogPof 4.6) Vibrio chlolerae quorum-sensing signal CAI-1
(S-3-hidroxytridecan-4-one) is a promising candidate for a quorum sensing agonist whose accumulation
induces transition of V. chlolerae to a non-biofilm forming non-virulence state. The process,
called “Flash-nanoprecipitation”, was used to incorporate this compound into nanoparticles of
polystyrene-block polyethylene glycol (PEG) and vitamin E to create a water dispersible form intended
for oral delivery. These particles activated V. chlolerae quorum-sensing responses five orders of
magnitude higher than the identically administered free CAI-1 does, and were able to diffuse across
murine small intestinal mucus [203].
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The combination of antibiotics and QSI might offer significant synergy such as reducing
bacterial virulence factor expression and thus protecting the host and making pathogens more
susceptible to immune defense [204]. Likewise, co-encapsulation of other antimicrobial substances
together with an antibiotic into liposomes could improve antimicrobial efficacy. The antibacterial
and antibiofilm activity of metals has supported its incorporation into these combinations. Thus,
the coencapsulation of gallium with gentamycin in dipalmitoyl phosphatidylcholine:dimirystoil
phosphatidylcholine:cholesterol (DPPC:DMPG:Chol) liposomes (Lipo-Ga Gen) showed better
antibiofilm activity against Pseudomonas aeruginosa than the free combination or each compound
separately. Only liposome formulation was able to suppress AHL production [205]. Other studies
with liposomes combining bismuth–ethanedithiol with tobramycin also showed the superior ability
of liposomes inhibiting the production of N-acyl homoserine lactone, and virulence factors elastase,
protease and chitinase [205–210].
Also, several niosome formulations, including tobramycin and bismuth-ethanedithiol,
were evaluated both alone and in combination as drug delivery systems with regards to quorum
sensing and biofilm formation in various strains of Pseudomonas aeruginosa. The composition of
niosomes included: Span 40, Tween 40 and 30% cholesterol. The incorporation in niosomes reduced
the minimum inhibitory concentration (MIC) of formulations including tobramycin in comparison
with the non-encapsulated ones. This has been attributed to an enhanced penetration of the antibiotic
in the cell [210]. Furthermore, 1:2 MIC and 1:4 MIC concentrations of the free and niosomal
bismuth-ethanedithiol tobramycin combinations were the most effective, inhibiting biofilm formation
by over 80%. These two formulations were also able to inhibit AHL production [211].
Despite the huge number of molecules described as quorum sensing inhibitors, as well as the
massive research about nanoparticles used for infections and biofilms treatments, not many studies
can be found about using nanoparticles in quorum quenching. However, nanoparticles as carriers of
QSI can overcome the unfavorable properties of many of these compounds. Furthermore, besides the
advantages of these systems based on their size, nanomaterials used may also have anti-QS activity.
The metallic NPs show promising results in QS inhibition but also other compounds as tensioactives
might have this activity. Further research in this interesting field must be done.
5. Conclusions
Numerous advances in nanoparticle-based systems for the diagnostic and treatment of bacterial
infections have been recently published with potential applications in the fight against multidrug
resistant strains and bacterial biofilms, among other areas. Those nanosystems may also be useful for
diagnoses and treatment of viral infections.
The characteristics of certain types of nanoparticles and additional functionalization confer
on them ideal properties for application in diagnostic analysis, even allowing miniaturization and
simplification of some traditional techniques of pathogen detection. Advanced analytical methods,
such as SERS, combined with the use of metallic nanoparticles are excellent tools for the detection
of bacteria and viruses. Also, other methods, such as plasmonic nanocavities or magnetic and
electrochemical biosensors, have been implemented. As a result, more sensitive and easy to use
techniques have been achieved. Moreover, nanoparticles constitute an interesting platform for
theranostic applications.
In addition, the inhibition of bacterial quorum sensing systems by the use of metallic and
other types of nanoparticles constitutes a promising strategy in the fight against bacterial infections.
The incorporation of QS inhibitors into these nanosystems increases their efficacy for biofilm treatment.
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.
Int. J. Mol. Sci. 2018, 19, 1627 18 of 28
References
1. Kannan, R.M.; Nance, E.; Kannan, S.; Tomalia, D.A. Emerging concepts in dendrimer-based nanomedicine:
From design principles to clinical applications. J. Intern. Med. 2014, 276, 579–617. [CrossRef] [PubMed]
2. Sundar, S.; Prajapati, V.K. Drug targeting to infectious diseases by nanoparticles surface functionalized with
special biomolecules. Curr. Med. Chem. 2012, 19, 3196–3202. [CrossRef] [PubMed]
3. Thorley, A.J.; Tetley, T.D. New perspectives in nanomedicine. Pharmacol. Ther. 2013, 140, 176–185. [CrossRef]
[PubMed]
4. Zazo, H.; Colino, C.I.; Lanao, J.M. Current applications of nanoparticles in infectious diseases. J. Control.
Release 2016, 224, 86–102. [CrossRef] [PubMed]
5. Roy, U.; Rodriguez, J.; Barber, P.; das Neves, J.; Sarmento, B.; Nair, M. The potential of HIV-1 nanotherapeutics:
From in vitro studies to clinical trials. Nanomedicine 2015, 10, 3597–3609. [CrossRef] [PubMed]
6. Burlage, R.S.; Tillmann, J. Biosensors of bacterial cells. J. Microbiol. Methods 2017, 138, 2–11. [CrossRef]
[PubMed]
7. Agrawal, S.; Prajapati, R. Nanosensors and their Pharmaceutical Applications: A Review. Int. J. Pharm. Sci.
Nanotechnol. 2012, 4, 1528–1535.
8. Chen, F.; Ehlerding, E.B.; Cai, W. Theranostic nanoparticles. J. Nucl. Med. 2014, 55, 1919–1922. [CrossRef]
[PubMed]
9. El Zowalaty, M.E.; Hussein Al Ali, S.H.; Husseiny, M.I.; Geilich, B.M.; Webster, T.J.; Hussein, M.Z.
The ability of streptomycin-loaded chitosan-coated magnetic nanocomposites to possess antimicrobial
and antituberculosis activities. Int. J. Nanomed. 2015, 10, 3269–3274. [CrossRef] [PubMed]
10. Perfezou, M.; Turner, A.; Merkoci, A. Cancer detection using nanoparticle-based sensors. Chem. Soc. Rev.
2012, 41, 2606–2622. [CrossRef] [PubMed]
11. Bohunicky, B.; Mousa, S.A. Biosensors: The new wave in cancer diagnosis. Nanotechnol. Sci. Appl. 2010, 4,
1–10. [PubMed]
12. Panagiotopoulou, M.; Kunath, S.; Medina-Rangel, P.X.; Haupt, K.; Tse Sum Bui, B. Fluorescent molecularly
imprinted polymers as plastic antibodies for selective labeling and imaging of hyaluronan and sialic acid on
fixed and living cells. Biosens. Bioelectron. 2017, 88, 85–93. [CrossRef] [PubMed]
13. Li, Z.; Su, W.; Liu, S.; Ding, X. An electrochemical biosensor based on DNA tetrahedron/graphene composite
film for highly sensitive detection of NADH. Biosens. Bioelectron. 2015, 69, 287–293. [CrossRef] [PubMed]
14. Fang, Y.-S.; Wang, H.-Y.; Wang, L.-S.; Wang, J.-F. Electrochemical immunoassay for procalcitonin antigen
detection based on signal amplification strategy of multiple nanocomposites. Biosens. Bioelectron. 2014, 51,
310–316. [CrossRef] [PubMed]
15. Wen, A.M.; Steinmetz, N.F. Design of virus-based nanomaterials for medicine, biotechnology, and energy.
Chem. Soc. Rev. 2016, 45, 4074–4126. [CrossRef] [PubMed]
16. Chen, Q.; Sun, Q.; Molino, N.M.; Wang, S.W.; Boder, E.T.; Chen, W. Sortase A-mediated multi-functionalization
of protein nanoparticles. Chem. Commun. 2015, 51, 12107–12110. [CrossRef] [PubMed]
17. Raeeszadeh-Sarmazdeh, M.; Hartzell, E.; Price, J.V.; Chen, W. Protein nanoparticles as multifunctional
biocatalysts and health assessment sensors. Curr. Opin. Chem. Eng. 2016, 13, 109–118. [CrossRef]
18. Park, J.S.; Cho, M.K.; Lee, E.J.; Ahn, K.Y.; Lee, K.E.; Jung, J.H.; Cho, Y.; Han, S.S.; Kim, Y.K.; Lee, J. A highly
sensitive and selective diagnostic assay based on virus nanoparticles. Nat. Nanotechnol. 2009, 4, 259–264.
[CrossRef] [PubMed]
19. Prow, T.W.; Kotov, N.A.; Lvov, Y.M.; Rijnbrand, R.; Leary, J.F. Nanoparticles, molecular biosensors, and
multispectral confocal microscopy. J. Mol. Histol. 2004, 35, 555–564. [CrossRef] [PubMed]
20. Buszewski, B.; Rogowska, A.; Pomastowski, P.; Zloch, M.; Railean-Plugaru, V. Identification of
Microorganisms by Modern Analytical Techniques. J. AOAC Int. 2017, 100, 1607–1623. [CrossRef] [PubMed]
21. Adzitey, F.; Huda, N.; Ali, G.R. Molecular techniques for detecting and typing of bacteria, advantages and
application to foodborne pathogens isolated from ducks. 3 Biotech 2013, 3, 97–107. [CrossRef] [PubMed]
22. Lin, H.Y.; Huang, C.H.; Hsieh, W.H.; Liu, L.H.; Lin, Y.C.; Chu, C.C.; Wang, S.T.; Kuo, I.T.; Chau, L.K.;
Yang, C.Y. On-line SERS detection of single bacterium using novel SERS nanoprobes and a microfluidic
dielectrophoresis device. Small 2014, 10, 4700–4710. [CrossRef] [PubMed]
23. Billard, P.; DuBow, M.S. Bioluminescence-based assays for detection and characterization of bacteria and
chemicals in clinical laboratories. Clin. Biochem. 1998, 31, 1–14. [CrossRef]
Int. J. Mol. Sci. 2018, 19, 1627 19 of 28
24. Blum, L.J.; Gautier, S.M.; Coulet, P.R. Design of luminescence photobiosensors. J. Biolumin. Chemilumin. 1989,
4, 543–550. [CrossRef] [PubMed]
25. Howes, P.D.; Rana, S.; Stevens, M.M. Plasmonic nanomaterials for biodiagnostics. Chem. Soc. Rev. 2014, 43,
3835–3853. [CrossRef] [PubMed]
26. Bohara, R.A.; Pawar, S.H. Innovative Developments in Bacterial Detection with Magnetic Nanoparticles.
Appl. Biochem. Biotechnol. 2015, 176, 1044–1058. [CrossRef] [PubMed]
27. Sulis, G.; Roggi, A.; Matteelli, A.; Raviglione, M.C. Tuberculosis: Epidemiology and control. Mediterr. J.
Hematol. Infect. Dis. 2014, 6, e2014070. [CrossRef] [PubMed]
28. Smith, I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin. Microbiol.
Rev. 2003, 16, 463–496. [CrossRef] [PubMed]
29. Barroso, T.G.; Martins, R.C.; Fernandes, E.; Cardoso, S.; Rivas, J.; Freitas, P.P. Detection of BCG bacteria
using a magnetoresistive biosensor: A step towards a fully electronic platform for tuberculosis point-of-care
detection. Biosens. Bioelectron. 2018, 100, 259–265. [CrossRef] [PubMed]
30. Kim, J.; Lee, K.S.; Kim, E.B.; Paik, S.; Chang, C.L.; Park, T.J.; Kim, H.J.; Lee, J. Early detection of the growth of
Mycobacterium tuberculosis using magnetophoretic immunoassay in liquid culture. Biosens. Bioelectron. 2017,
96, 68–76. [CrossRef] [PubMed]
31. Prochazka, M. Basics of Surface-Enhanced Raman Scattering (SERS). In Surface-Enhanced Raman Spectroscopy:
Bioanalytical, Biomolecular and Medical Applications; Springer International Publishing: Cham, Switzerland,
2016; pp. 21–59.
32. Wang, F.; Cao, S.; Yan, R.; Wang, Z.; Wang, D.; Yang, H. Selectivity/Specificity Improvement Strategies in
Surface-Enhanced Raman Spectroscopy Analysis. Sensors 2017, 17, 2689. [CrossRef] [PubMed]
33. Mosier-Boss, P.A. Review on SERS of Bacteria. Biosensors 2017, 7, 51. [CrossRef] [PubMed]
34. Liu, T.; Gao, L.; Zhao, J.; Cao, Y.; Tang, Y.; Miao, P. A polymyxin B-silver nanoparticle colloidal system and
the application of lipopolysaccharide analysis. Analyst 2018, 143, 1053–1058. [CrossRef] [PubMed]
35. Fabris, L. Gold-based SERS tags for biomedical imaging. J. Opt. 2015, 17, 114002. [CrossRef]
36. Guarrotxena, N.; Bazan, G.C. Antibody-functionalized SERS tags with improved sensitivity. Chem. Commun.
2011, 47, 8784–8786. [CrossRef] [PubMed]
37. Indrasekara, A.S.; Paladini, B.J.; Naczynski, D.J.; Starovoytov, V.; Moghe, P.V.; Fabris, L. Dimeric gold
nanoparticle assemblies as tags for SERS-based cancer detection. Adv. Healthc. Mater. 2013, 2, 1370–1376.
[CrossRef] [PubMed]
38. Lin, Y.; Hamme Ii, A.T. Targeted highly sensitive detection/eradication of multi-drug resistant Salmonella
DT104 through gold nanoparticle-SWCNT bioconjugated nanohybrids. Analyst 2014, 139, 3702–3705.
[CrossRef] [PubMed]
39. Cheng, H.W.; Chen, Y.Y.; Lin, X.X.; Huan, S.Y.; Wu, H.L.; Shen, G.L.; Yu, R.Q. Surface-enhanced Raman
spectroscopic detection of Bacillus subtilis spores using gold nanoparticle based substrates. Anal. Chim. Acta
2011, 707, 155–163. [CrossRef] [PubMed]
40. Boardman, A.K.; Campbell, J.; Wirz, H.; Sharon, A.; Sauer-Budge, A.F. Rapid microbial sample preparation
from blood using a novel concentration device. PLoS ONE 2015, 10, e0116837. [CrossRef] [PubMed]
41. Boardman, A.K.; Wong, W.S.; Premasiri, W.R.; Ziegler, L.D.; Lee, J.C.; Miljkovic, M.; Klapperich, C.M.;
Sharon, A.; Sauer-Budge, A.F. Rapid Detection of Bacteria from Blood with Surface-Enhanced Raman
Spectroscopy. Anal. Chem. 2016, 88, 8026–8035. [CrossRef] [PubMed]
42. Dina, N.E.; Zhou, H.; Colnita, A.; Leopold, N.; Szoke-Nagy, T.; Coman, C.; Haisch, C. Rapid single-cell
detection and identification of pathogens by using surface-enhanced Raman spectroscopy. Analyst 2017, 142,
1782–1789. [CrossRef] [PubMed]
43. Cheong, Y.; Kim, Y.J.; Kang, H.; Choi, S.; Lee, H.J. Rapid label-free identification of Klebsiella pneumoniae
antibiotic resistant strains by the drop-coating deposition surface-enhanced Raman scattering method.
Spectrochim. Acta A Mol. Biomol. Spectrosc. 2017, 183, 53–59. [CrossRef] [PubMed]
44. Lauridsen, R.K.; Sommer, L.M.; Johansen, H.K.; Rindzevicius, T.; Molin, S.; Jelsbak, L.; Engelsen, S.B.;
Boisen, A. SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated
from cystic fibrosis patients. Sci. Rep. 2017, 7, 45264. [CrossRef] [PubMed]
45. Spackova, B.; Wrobel, P.; Bockova, M.; Homola, J. Optical Biosensors Based on Plasmonic Nanostructures:
A Review. J. Proc. IEEE 2016, 104, 2380–2408. [CrossRef]
Int. J. Mol. Sci. 2018, 19, 1627 20 of 28
46. Rippa, M.; Castagna, R.; Pannico, M.; Musto, P.; Bobeico, E.; Zhou, J.; Petti, L. High-performance
nanocavities-based meta-crystals for enhanced plasmonic sensing. Opt. Data Process. Storage 2016, 2, 22–26.
[CrossRef]
47. Dhama, R.; Caligiuri, V.; Petti, L.; Rashed, A.R.; Rippa, M.; Lento, R.; Termine, R.; Caglayan, H.; De Luca, A.
Extraordinary Effects in Quasi-Periodic Gold Nanocavities: Enhanced Transmission and Polarization Control
of Cavity Modes. ACS Nano 2018, 12, 504–512. [CrossRef] [PubMed]
48. Rippa, M.; Castagna, R.; Pannico, M.; Musto, P.; Borriello, G.; Paradiso, R.; Galiero, G.; Bolletti Censi, S.;
Zhou, J.; Zyss, J.; et al. Octupolar Metastructures for a Highly Sensitive, Rapid, and Reproducible
Phage-Based Detection of Bacterial Pathogens by Surface-Enhanced Raman Scattering. ACS Sens. 2017, 2,
947–954. [CrossRef] [PubMed]
49. Zhang, M.; Li, C.; Wang, C.; Wang, T.; Zhang, T.; Zheng, H. Tunable Ultrahigh Order Surface Plasmonic
Resonance in Multi-Ring Plasmonic Nanocavities. Plasmonics 2017, 12, 1773–1779. [CrossRef]
50. Halford, C.; Gau, V.; Churchill, B.M.; Haake, D.A. Bacterial detection & identification using electrochemical
sensors. J. Vis. Exp. 2013, e4282. [CrossRef]
51. Goluch, E.D. Microbial Identification Using Electrochemical Detection of Metabolites. Trends Biotechnol. 2017,
35, 1125–1128. [CrossRef] [PubMed]
52. Sismaet, H.J.; Goluch, E.D. Electrochemical Probes of Microbial Community Behavior. Annu. Rev. Anal.
Chem. 2018, 11. [CrossRef] [PubMed]
53. Wang, Y.; Alocilja, E.C. Gold nanoparticle-labeled biosensor for rapid and sensitive detection of bacterial
pathogens. J. Biol. Eng. 2015, 9, 16. [CrossRef] [PubMed]
54. Wang, L.; Huang, F.; Cai, G.; Yao, L.; Zhang, H.; Lin, J. An Electrochemical Aptasensor Using Coaxial
Capillary with Magnetic Nanoparticle, Urease Catalysis and PCB Electrode for Rapid and Sensitive Detection
of Escherichia coli O157:H7. Nanotheranostics 2017, 1, 403–414. [CrossRef] [PubMed]
55. Pyo, H.; Lee, C.Y.; Kim, D.; Kim, G.; Lee, S.; Yun, W.S. Electrical Detection of Pneumococcus through the
Nanoparticle Decoration Method. Sensors 2017, 17, 2012. [CrossRef] [PubMed]
56. Sepunaru, L.; Tschulik, K.; Batchelor-McAuley, C.; Gavish, R.; Compton, R.G. Electrochemical detection of
single E. coli bacteria labeled with silver nanoparticles. Biomater. Sci. 2015, 3, 816–820. [CrossRef] [PubMed]
57. Morones, J.R.; Elechiguerra, J.L.; Camacho, A.; Holt, K.; Kouri, J.B.; Ramirez, J.T.; Yacaman, M.J.
The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16, 2346–2353. [CrossRef] [PubMed]
58. Wu, R.; Ma, Y.; Pan, J.; Lee, S.H.; Liu, J.; Zhu, H.; Gu, R.; Shea, K.J.; Pan, G. Efficient capture, rapid killing and
ultrasensitive detection of bacteria by a nano-decorated multi-functional electrode sensor. Biosens. Bioelectron.
2018, 101, 52–59. [CrossRef] [PubMed]
59. Chen, Z.Z.; Cai, L.; Chen, M.Y.; Lin, Y.; Pang, D.W.; Tang, H.W. Indirect immunofluorescence detection of E.
coli O157:H7 with fluorescent silica nanoparticles. Biosens. Bioelectron. 2015, 66, 95–102. [CrossRef] [PubMed]
60. Qi, G.; Li, L.; Yu, F.; Wang, H. Vancomycin-modified mesoporous silica nanoparticles for selective recognition
and killing of pathogenic gram-positive bacteria over macrophage-like cells. ACS Appl. Mater. Interfaces 2013,
5, 10874–10881. [CrossRef] [PubMed]
61. Ellairaja, S.; Krithiga, N.; Ponmariappan, S.; Vasantha, V.S. Novel Pyrimidine Tagged Silver Nanoparticle
Based Fluorescent Immunoassay for the Detection of Pseudomonas aeruginosa. J. Agric. Food Chem. 2017, 65,
1802–1812. [CrossRef] [PubMed]
62. Li, H.; Qiang, W.; Vuki, M.; Xu, D.; Chen, H.-Y. Fluorescence Enhancement of Silver Nanoparticle Hybrid
Probes and Ultrasensitive Detection of IgE. Anal. Chem. 2011, 83, 8945–8952. [CrossRef] [PubMed]
63. Wang, R.; Xu, Y.; Jiang, Y.; Chuan, N.; Su, X.; Ji, J. Sensitive quantification and visual detection of bacteria
using CdSe/ZnS@SiO2 nanoparticles as fluorescent probes. Anal. Methods 2014, 6, 6802–6808. [CrossRef]
64. Mazrad, Z.A.I.; Choi, C.A.; Kwon, Y.M.; In, I.; Lee, K.D.; Park, S.Y. Design of Surface-Coatable
NIR-Responsive Fluorescent Nanoparticles with PEI Passivation for Bacterial Detection and Killing.
ACS Appl. Mater. Interfaces 2017, 9, 33317–33326. [CrossRef] [PubMed]
65. Pacheco, M.; Jurado-Sanchez, B.; Escarpa, A. Sensitive Monitoring of Enterobacterial Contamination of Food
Using Self-Propelled Janus Microsensors. Anal. Chem. 2018, 90, 2912–2917. [CrossRef] [PubMed]
66. Jurado-Sanchez, B.; Pacheco, M.; Rojo, J.; Escarpa, A. Magnetocatalytic Graphene Quantum Dots Janus
Micromotors for Bacterial Endotoxin Detection. Angew. Chem. Int. Ed. Engl. 2017, 56, 6957–6961. [CrossRef]
[PubMed]
67. Warren, C.W.C. (Ed.) Bio-Applications of Nanoparticles; Springer: New York, NY, USA, 2007; Volume 620.
Int. J. Mol. Sci. 2018, 19, 1627 21 of 28
68. Sekar, R.B.; Periasamy, A. Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell
protein localizations. J. Cell Biol. 2003, 160, 629–633. [CrossRef] [PubMed]
69. Buntru, A.; Zimmermann, T.; Hauck, C.R. Fluorescence resonance energy transfer (FRET)-based subcellular
visualization of pathogen-induced host receptor signaling. BMC Biol. 2009, 7, 81. [CrossRef] [PubMed]
70. Mansour, A.; Tammam, S.; Althani, A.; Azzazy, H.M.E. A single tube system for the detection of
Mycobacterium tuberculosis DNA using gold nanoparticles based FRET assay. J. Microbiol. Methods 2017, 139,
165–167. [CrossRef] [PubMed]
71. Yadavalli, T.; Shukla, D. Role of metal and metal oxide nanoparticles as diagnostic and therapeutic tools for
highly prevalent viral infections. Nanomedicine 2017, 13, 219–230. [CrossRef] [PubMed]
72. Zazo, H.; Millán, C.G.; Colino, C.I.; Lanao, J.M. Chapter 15—Applications of Metallic Nanoparticles in
Antimicrobial Therapy. In Antimicrobial Nanoarchitectonics; Grumezescu, A.M., Ed.; Elsevier: New York, NY,
USA, 2017; pp. 411–444.
73. Shevtsov, M.; Zhao, L.; Protzer, U.; Klundert, M. Applicability of Metal Nanoparticles in the Detection and
Monitoring of Hepatitis B Virus Infection. Viruses 2017, 9, 193. [CrossRef] [PubMed]
74. Yildiz, U.H.; Inci, F.; Wang, S.; Toy, M.; Tekin, H.C.; Javaid, A.; Lau, D.T.; Demirci, U. Recent advances
in micro/nanotechnologies for global control of hepatitis B infection. Biotechnol. Adv. 2015, 33, 178–190.
[CrossRef] [PubMed]
75. Mahajan, S.D.; Aalinkeel, R.; Law, W.C.; Reynolds, J.L.; Nair, B.B.; Sykes, D.E.; Yong, K.T.; Roy, I.; Prasad, P.N.;
Schwartz, S.A. Anti-HIV-1 nanotherapeutics: Promises and challenges for the future. Int. J. Nanomed. 2012, 7,
5301–5314. [CrossRef] [PubMed]
76. Moulick, A.; Richtera, L.; Milosavljevic, V.; Cernei, N.; Haddad, Y.; Zitka, O.; Kopel, P.; Heger, Z.; Adam, V.
Advanced nanotechnologies in avian influenza: Current status and future trends—A review. Anal. Chim.
Acta 2017, 983, 42–53. [CrossRef] [PubMed]
77. Hassanpour, S.; Baradaran, B.; Hejazi, M.; Hasanzadeh, M.; Mokhtarzadeh, A.; de la Guardia, M. Recent
trends in rapid detection of influenza infections by bio and nanobiosensor. TrAC Trends Anal. Chem. 2018, 98,
201–215. [CrossRef]
78. Srinivasan, A.; Rastogi, A.; Ayyavoo, V.; Srivastava, S. Nanotechnology-based approaches for the development
of diagnostics, therapeutics, and vaccines. Monoclon. Antib. Immunodiagn. Immunother. 2014, 33, 186–191.
[CrossRef] [PubMed]
79. Lee, K.L.; Twyman, R.M.; Fiering, S.; Steinmetz, N.F. Virus-based nanoparticles as platform technologies for
modern vaccines. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2016, 8, 554–578. [CrossRef] [PubMed]
80. Shen, L.; Zhou, J.; Wang, Y.; Kang, N.; Ke, X.; Bi, S.; Ren, L. Efficient encapsulation of Fe(3)O(4) nanoparticles
into genetically engineered hepatitis B core virus-like particles through a specific interaction for potential
bioapplications. Small 2015, 11, 1190–1196. [CrossRef] [PubMed]
81. Jang, K.J.; Lee, H.; Jin, H.L.; Park, Y.; Nam, J.M. Restriction-enzyme-coded gold-nanoparticle probes for
multiplexed DNA detection. Small 2009, 5, 2665–2668. [CrossRef] [PubMed]
82. Jorquera, P.A.; Tripp, R.A. Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the
Respiratory Syncytial Virus. Vaccines 2016, 4, 45. [CrossRef] [PubMed]
83. Tamanaha, C.R.; Mulvaney, S.P.; Rife, J.C.; Whitman, L.J. Magnetic labeling, detection, and system integration.
Biosens. Bioelectron. 2008, 24, 1–13. [CrossRef] [PubMed]
84. Xi, Z.; Huang, R.; Li, Z.; He, N.; Wang, T.; Su, E.; Deng, Y. Selection of HBsAg-Specific DNA Aptamers
Based on Carboxylated Magnetic Nanoparticles and Their Application in the Rapid and Simple Detection of
Hepatitis B Virus Infection. ACS Appl. Mater. Interfaces 2015, 7, 11215–11223. [CrossRef] [PubMed]
85. Yang, H.; Liang, W.; Si, J.; Li, Z.; He, N. Long spacer arm-functionalized magnetic nanoparticle platform
for enhanced chemiluminescent detection of hepatitis B virus. J. Biomed. Nanotechnol. 2014, 10, 3610–3619.
[CrossRef] [PubMed]
86. Wang, W.; Ma, P.; Dong, H.; Krause, H.J.; Zhang, Y.; Willbold, D.; Offenhaeusser, A.; Gu, Z. A magnetic
nanoparticles relaxation sensor for protein-protein interaction detection at ultra-low magnetic field.
Biosens. Bioelectron. 2016, 80, 661–665. [CrossRef] [PubMed]
87. Fatemi, K.; Ghourchian, H.; Ziaee, A.A.; Samiei, S.; Hanaee, H. Paramagnetic nanoparticle-based detection
of hepatitis B virus using cathodic stripping voltammetry. Biotechnol. Appl. Biochem. 2009, 52, 221–225.
[CrossRef] [PubMed]
Int. J. Mol. Sci. 2018, 19, 1627 22 of 28
88. Kamikawa, T.L.; Mikolajczyk, M.G.; Kennedy, M.; Zhang, P.; Wang, W.; Scott, D.E.; Alocilja, E.C.
Nanoparticle-based biosensor for the detection of emerging pandemic influenza strains. Biosens. Bioelectron.
2010, 26, 1346–1352. [CrossRef] [PubMed]
89. Wang, R.; Lin, J.; Lassiter, K.; Srinivasan, B.; Lin, L.; Lu, H.; Tung, S.; Hargis, B.; Bottje, W.; Berghman, L.; et al.
Evaluation study of a portable impedance biosensor for detection of avian influenza virus. J. Virol. Methods
2011, 178, 52–58. [CrossRef] [PubMed]
90. Jimenez Jimenez, A.M.; Ruttkay-Nedecky, B.; Dostalova, S.; Krejcova, L.; Michalek, P.; Richtera, L.;
Adam, V. Specific Magnetic Isolation of E6 HPV16 Modified Magnetizable Particles Coupled with PCR and
Electrochemical Detection. Int. J. Mol. Sci. 2016, 17, 585. [CrossRef] [PubMed]
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200. Ilk, S.; Sağlam, N.; Özgen, M.; Korkusuz, F. Chitosan nanoparticles enhances the anti-quorum sensing
activity of kaempferol. Int. J. Biol. Macromol. 2017, 94, 653–662. [CrossRef] [PubMed]
201. Omwenga, E.O.; Hensel, A.; Shitandi, A.; Goycoolea, F.M. Chitosan nanoencapsulation of flavonoids
enhances their quorum sensing and biofilm formation inhibitory activities against an E. coli Top 10 biosensor.
Colloids Surf. B Biointerfaces 2018, 164, 125–133. [CrossRef] [PubMed]
202. Nafee, N.; Husari, A.; Maurer, C.K.; Lu, C.; de Rossi, C.; Steinbach, A.; Hartmann, R.W.; Lehr, C.M.;
Schneider, M. Antibiotic-free nanotherapeutics: Ultra-small, mucus-penetrating solid lipid nanoparticles
enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors. J. Control.
Release 2014, 192, 131–140. [CrossRef] [PubMed]
203. Lu, H.D.; Spiegel, A.C.; Hurley, A.; Perez, L.J.; Maisel, K.; Ensign, L.M.; Hanes, J.; Bassler, B.L.;
Semmelhack, M.F.; Prud’homme, R.K. Modulating Vibrio cholerae quorum-sensing-controlled communication
using autoinducer-loaded nanoparticles. Nano Lett. 2015, 15, 2235–2241. [CrossRef] [PubMed]
204. Christensen, L.D.; van Gennip, M.; Jakobsen, T.H.; Alhede, M.; Hougen, H.P.; Hoiby, N.; Bjarnsholt, T.;
Givskov, M. Synergistic antibacterial efficacy of early combination treatment with tobramycin and
quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection
mouse model. J. Antimicrob. Chemother. 2012, 67, 1198–1206. [CrossRef] [PubMed]
205. Halwani, M.; Yebio, B.; Suntres, Z.E.; Alipour, M.; Azghani, A.O.; Omri, A. Co-encapsulation of gallium
with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
J. Antimicrob. Chemother. 2008, 62, 1291–1297. [CrossRef] [PubMed]
206. Halwani, M.; Blomme, S.; Suntres, Z.E.; Alipour, M.; Azghani, A.O.; Kumar, A.; Omri, A. Liposomal
bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin. Int. J. Pharm. 2008, 358,
278–284. [CrossRef] [PubMed]
207. Halwani, M.; Hebert, S.; Suntres, Z.E.; Lafrenie, R.M.; Azghani, A.O.; Omri, A. Bismuth-thiol incorporation
enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing
molecules production by Pseudomonas aeruginosa. Int. J. Pharm. 2009, 373, 141–146. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2018, 19, 1627 28 of 28
208. Alipour, M.; Suntres, Z.E.; Lafrenie, R.M.; Omri, A. Attenuation of Pseudomonas aeruginosa virulence factors
and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomes. J. Antimicrob.
Chemother. 2010, 65, 684–693. [CrossRef] [PubMed]
209. Alhariri, M.; Omri, A. Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal
administration in rats with pulmonary Pseudomonas aeruginosa infection. Antimicrob. Agents Chemother. 2013,
57, 569–578. [CrossRef] [PubMed]
210. Alipour, M.; Dorval, C.; Suntres, Z.E.; Omri, A. Bismuth-ethanedithiol incorporated in a liposome-loaded
tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa. J. Pharm.
Pharmacol. 2011, 63, 999–1007. [CrossRef] [PubMed]
211. Mahdiun, F.; Mansouri, S.; Khazaeli, P.; Mirzaei, R. The effect of tobramycin incorporated with
bismuth-ethanedithiol loaded on niosomes on the quorum sensing and biofilm formation of Pseudomonas
aeruginosa. Microb. Pathog. 2017, 107, 129–135. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
